Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in MGNX — Macrogenics Inc

CIK 1179392 NEW YORK, NY
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,391,529
+$4,086,104 QoQ
Shares Held
2,465,699
-2.5% QoQ
Ownership
3.87%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 122 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. MGNX ranks #81 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in MGNX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,391,529 2,465,699
2026-03-31 $7,305,425 2,527,829
2025-12-31 $1,609,153 999,474
2025-09-30 $734,312 437,091
2025-06-30 $492,818 407,288
2025-03-31 $831,720 654,898
2024-12-31 $2,797,421 860,745
2024-09-30 $2,906,284 883,369
2024-06-30 $5,201,970 1,223,993
2024-03-31 $196,703 13,363
2023-12-31 $491,226 51,063
2023-09-30 $244,943 52,563
2023-06-30 $1,656,584 309,642
2023-03-31 $4,873,843 679,755
2022-12-31 $4,706,011 701,343
2022-09-30 $1,362,143 393,683
2022-06-30 $2,928,072 992,567
2022-03-31 $3,177,714 360,694
2021-12-31 $251,150 15,648
2021-03-31 $1,421,306 44,625
2020-12-31 $2,939,064 128,568
2020-09-30 $4,124,257 163,726
2020-06-30 $4,643,151 166,302
2020-03-31 $483,286 83,039